pfizer2, medichem

custom search

REVERSED
Tech Center 1700 Chemical & Materials Engineering
1732 Ex Parte Caudle 12263864 - (D) COLAIANNI 103 WOMBLE BOND DICKINSON (US) LLP FORREST, MICHAEL

1784 Ex Parte Boileau et al 14068101 - (D) DENNETT 112(1) BROOKS KUSHMAN P.C./FG1L SCHLEIS, DANIEL J

1788 Ex Parte Tsumagari et al 13517196 - (D) OWENS 103 LEYDIG VOIT & MA YER, LTD PATEL, RONAK C

Tech Center 2100 Computer Architecture and Software
2132 Ex Parte Khodabandehlou et al 15273426 - (D) EVANS 103 CYPRESS SEMICONDUCTOR CORPORATION MERCADO, RAMON A

2164 Ex Parte Hahn et al 12607551 - (D) FENICK 103 BGL/ MAHMOOD, REZWANUL

2173 Ex Parte Louch 13340605 - (D) SAADAT 103 DENTONS US LLP - Apple HAILU, TADESSE

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2473 Ex Parte Rimhagen et al 14623182 - (D) KHAN 103 COATS & BENNETT, PLLC NGO, NGUYEN HOANG

2493 Ex Parte He 13290083 - (D) FENICK 103 Jianping He LAYELLE, GARY E

Tech Center 2600 Communications
2618 Ex Parte Saulters et al 13754256 - (D) CURCURI 103 Artegis Law Group, LLP/NVIDIA WANG, YUEHAN

2622 Ex Parte Starner et al 14706839 - (D) AMUNDSON 103 McDonnell Boehnen Hulbert & Berghoff LLP/Google LLC PATEL, SANJIV D

2646 Ex Parte Hus 11576751 - (D) SAADAT 103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS KELLEY, STEVEN SHAUN

2647 Ex Parte Hanson et al 14399581 - (D) McCARTNEY 103 Fogg & Powers LLC/Commscope CHEN, ZHITONG

2658 Ex Parte Yassa 13284973 - (D) EVANS 103 SUGHRUE MION, PLLC COLUCCI, MICHAEL C

2688 Ex Parte Ahner et al 15277924 - (D) McCARTNEY 102/103 Rimon Law - SEA GA TE BUTCHER, BRIAN M

2694 Ex Parte NICHOLSON 14508395 - (D) KOHUT 103 PERRY+ CURRIER INC. SITTA, GRANT

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3617 Ex Parte Dumalski et al 13804932 - (D) WIEDER 103 FROST BROWN TODD LLC KUHFUSS, ZACHARY L

3621 Ex Parte Hall et al 12323670 - (D) FETTING 112(1)/101/103 Middleton Reutlinger (IBMP) ZELASKIEWICZ, CHRYSTINA E

3623 Ex Parte Nyhan et al 09900674 - (D) FISCHETTI 101 LEYDIG VOIT & MA YER, LTD BOYCE, ANDRE D

3685 Ex Parte Fujioka 13852840 - (D) FISCHETTI 103 Mattel, Inc. - Patent Group HUANG, JAY

3688 Ex Parte Avedissian 14045235 - (D) CUTITTA 101 41.50 112(1) KNOBBE MARTENS OLSON & BEAR LLP NETZLOFF, ERIC R

3688 Ex Parte Redford et al 14094363 - (D) FISCHETTI 101/102 KILPATRICK TOWNSEND & STOCKTONLLP/VISA ALVAREZ, RAQUEL

3692 Ex Parte Smith et al 13533822 - (D) WHITEHEAD JR. 101 Kilpatrick Townsend & Stockton LLP Adobe Systems, Inc. 58083 EBERSMAN, BRUCE I

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3711 Ex Parte Simonutti 15229447 - (D) PESLAK 103 Amer Sports Americas STANCZAK, MATTHEW BRIAN

"[T]o have a reasonable expectation of success, one must be motivated to do more than merely to vary all parameters or try each of numerous possible choices until one possibly arrived at a successful result." Pfizer, Inc. v. Apotex, Inc., 480 F.3d 1348, 1365 (Fed. Cir. 2007) (quoting Medichem, S.A. v. Rolabo, S.L., 437 F.3d 1157, 1165 (Fed. Cir. 2006)).

Pfizer, Inc. v. Apotex Inc., 480 F.3d 1348, 82 USPQd 1321 (Fed. Cir. 2007) 2143.01, 2145

3761 Ex Parte Hirano et al 13879882 - (D) KERINS 103 Locke Lord LLP FUQUA, SHAWNTINA T

AFFIRMED-IN-PART
Tech Center 1700 Chemical & Materials Engineering
1712 Ex Parte Harris et al 10553359 - (D) HANLON 103 112(2) SMITH, GAMBRELL & RUSSELL, LLP EMPIE, NATHAN H

1716 Ex Parte Schoeb 13045437 - (D) HASTINGS 103 103 KILPATRICK TOWNSEND & STOCKTONLLP MACARTHUR, SYLVIA

1789 Ex Parte Tanaka et al 13203582 - (D) REN 103 103 OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. MCKINNON, LASHAWNDA T

Tech Center 2100 Computer Architecture and Software
2165 Ex Parte Cheng et al 13773499 - (D) CURCURI 103 OTDP FISH & RICHARDSON P.C. SYED, FARHAN M

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2465 Ex Parte Frenne et al 13989833 - (D) SHAW 103 103 Murphy, Bilak & Homiller/Ericsson WILLIAMS, ELTON S

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2862 Ex Parte Ashbrook 13630898 - (D) GUPTA 103 103 Nokia Corporation and Alston & Bird LLP c/o Alston & Bird LLP PETERS, LISA E

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3731 Ex Parte Allen 13686593 - (D) HILL 102/103 102/103 MAGINOT, MOORE & BECK, LLP WITTENSCHLAEGER, THOMAS M

3732 Ex Parte BRAVERMAN 13839566 - (D) BAHR 103 103 GREENBLUM & BERNSTEIN, P.L.C. HUYNH, KHOA D

AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1611 Ex Parte Asmussen et al 12525888 - (D) TOWNSEND 103 HAUG PARTNERS LLP GHALI, ISIS AD

1618 Ex Parte Burba et al 13159179 - (D) NEW 102/103 Sheridan Ross PC VU, JAKE MINH

1618 Ex Parte WEI et al 13707108 - (D) VALEK 103 THE PROCTER & GAMBLE COMPANY VU, JAKE MINH

1619 Ex Parte Gerber et al 14240008 - (D) LEBOVITZ 103 HAUG PARTNERS LLP CHICKOS, SARAH J

1621 Ex Parte ABREU 13554349 - (D) TOWNSEND 103 Studebaker & Brackett PC QAZI, SABIHA NAIM

1626 Ex Parte Shi et al 14822918 - (D) LEBOVITZ 112(1)/112(2)/112(4)/102/103 US ARMY RESEARCH LABORATORY STOCKTON, LAURAL YNNE

1627 Ex Parte Dunayevich et al 13991372 - (D) CHANG 103 SERVILLA WHITNEY LLC IVANOVA, SVETLANA M

Tech Center 1700 Chemical & Materials Engineering
1716 Ex Parte KUDELA et al 13764832 - (D) WILSON 103 PATTERSON & SHERIDAN, LLP- -Applied Materials DHINGRA, RAKESH KUMAR

1717 Ex Parte Yakovleva et al 14496453 - (D) WILSON 103 Williams Mullen HERNANDEZ-DIAZ, JOSE

1722 Ex Parte LIU et al 13926764 - (D) HOUSEL 103 Mintz Levin/Rohm&Haas/Dow WALKE, AMANDA C

1733 Ex Parte Rabiei 13843110 - (D) SNAY 103 WOMBLE BOND DICKINSON (US) LLP ZHU, WEIPING

1734 Ex Parte Cui et al 14706151 - (D) DELMENDO 103 McNees Wallace & Nurick LLC JOHNSON, JONATHAN J

1741 Ex Parte Muthigi et al 14674367 - (D) WILSON 112(1)/102/103 THE GOODYEAR TIRE & RUBBER COMPANY FRANKLIN, JODI COHEN

1745 Ex Parte Wiley 14279035 - (D) WILSON 103 KNOBBE MARTENS OLSON & BEAR LLP OSELE, MARK A

1764 Ex Parte Satrijo et al 13876615 - (D) SMITH 103 3M INNOVATIVE PROPERTIES COMPANY REDDY, KARUNA P

1771 Ex Parte LANDSCHOF et al 13324166 - (D) WILSON 103 SHELL OIL COMPANY HINES, LATOSHA D

1772 Ex Parte Rolland 14033953 - (D) ROBERTSON 103 MILLEN, WHITE, ZELANO & BRANIGAN, P.C. PIERPONT, AARON W

1787 Ex Parte Yeung et al 12107396 - (D) WILSON 103 112(1) GREER, BURNS & CRAIN, LTD. FREEMAN, JOHN D

1793 Ex Parte Stauffer 13886650 - (D) DELMENDO 103 HAYNES AND BOONE, LLP MORNHINWEG, JEFFREY P

Tech Center 2100 Computer Architecture and Software
2165 Ex Parte SAKAINO et al 14081952 - (D) BENNETT 103 NIXON & VANDERHYE, P.C. BOWEN, RICHARD L

2169 Ex Parte Lewis 14074584 - (D) KOHUT 103 SCHWEGMAN LUNDBERG & WOESSNER/EBAY ALLEN, BRITTANY N

2173 Ex Parte Magarshak 13284901 - (D) RAEVSKY 103 KANG LIM CHAUDHURI, ANITA

2176 Ex Parte STYLE 14109118 - (D) SILVERMAN 103 NIXON & VANDERHYE, P.C. DYER, ANDREW R

2176 Ex Parte PARK 14220601 - (D) BENNETT 103 Jefferson IP Law, LLP JOSEPH, SHAWN S

2192 Ex Parte NUGTEREN et al 14557881 - (D) RAEVSKY 103 NIXON & VANDERHYE, P.C. WEI, ZHENG

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2422 Ex Parte Grundhofer et al 14844165 - (D) MORGAN 102 Disney Enterprises, Inc. c/o Dorsey & Whitney LLP MONSHI, SAMIRA

2426 Ex Parte Wong et al 13076937 - (D) CURCURI 103 112(2)/103 MAYER & WILLIAMS PC HUYNH, AN SON PHI

Tech Center 2600 Communications
2618 Ex Parte ICHIHASHI 14620391 - (D) KRIVAK 103 Paratus Law Group, PLLC RICHER, AARON M

2658 Ex Parte Cao et al 13267738 - (D) COURTENAY 103 DENTONS US LLP - Apple ADESANYA, OLUJIMI A

2659 Ex Parte KLAPAFTIS et al 13922852 - (D) CURCURI 103 SHOOK, HARDY & BACON L.L.P. (MICROSOFT TECHNOLOGY LICENSING, LLC) TZENG, FENG-TZER

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3624 Ex Parte Mussman 12822259 - (D) CRAWFORD 101 Proactive Patents LLC ROTARU, OCTAVIAN

3624 Ex Parte Gruber et al 13251104 - (D) FETTING 101/103 DENTONS US LLP - Apple ZIMMERMAN, JEFFREY P

3626 Ex Parte Giftakis et al 12236260 - (D) MEYERS 103 101 SHUMAKER & SIEFFERT, P.A PORTER, RACHELL

3677 Ex Parte Finkelstein 14566318 - (D) DOUGAL 103 Atlanta Baker Donelson O BRIEN, JEFFREY D

3687 Ex Parte Siauw et al 13460127 - (D) SHAH 101 Kilpatrick Townsend & Stockton LLP/Oracle CRAWLEY, TALIAF

3691 Ex Parte EBERLE et al 13774491 - (D) McCARTNEY 101 Bottomline Technologies (DE), Inc. KAZIMI, HAN! M

3692 Ex Parte Lee et al 13224763 - (D) BARRY 101 Venable LLP WONG, ERIC TAK WAI

3695 Ex Parte Becerra et al 12313740 - (D) McCARTNEY 101 Brient IP Law, LLC POLLOCK, GREGORY A

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3731 Ex Parte Schieler et al 13632114 - (D) STEPINA 103 Neal, Gerber & Eisenberg LLP (ITW) TECCO, ANDREW M

3745 Ex Parte Gautschi et al 14683408 - (D) BAHR 102/103 Bachman & LaPointe, P.C. DELRUE, BRIAN CHRISTOPHER

3762 Ex Parte Willemen 13267102 - (D) WARNER 103 THOMPSON HINE LLP / ITW LIN, KO-WEI

3773 Ex Parte Koltz et al 13799598 - (D) FITZPATRICK 103 DICKE, BILLIG & CZAJA, PLLC ATTN: MDT SURGICAL TECHNOLOGIES MATTERS CARTER, TARA ROSE E

3775 Ex Parte Baptist 14044724 - (D) NEW 103 Loza & Loza, LLP COLEY, ZADE JAMES

3781 Ex Parte HAMILTON et al 14309129 - (D) CRAWFORD 103 THE PROCTER & GAMBLE COMPANY KIDWELL, MICHELE M

3793 Ex Parte Boyd et al 14342984 - (D) STEPINA 103 Hoffmann and Baron, LLP BEHRINGER, LUTHER G

3794 Ex Parte Ladtkow 13477307 - (D) OSINSKI 112(1) Covidien LP KIM, EUN HWA

pfizer2, newell

custom search

REVERSED
Tech Center 1700 Chemical & Materials Engineering
1733 Ex Parte Sugitatsu et al 11627165 - (D) NAGUMO 103 OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. ZHU, WEIPING

AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1611 Ex Parte Chia et al 11978433 - (D) MILLS 103 The Dow Chemical Company ROHM AND HAAS COMPANY PURDY, KYLE A

See also, Pfizer, Inc. v. Apotex, Inc., 480 F.3d 1348, 1372 (Fed. Cir. 2007), holding secondary considerations may not be sufficient to overcome a prima facie case. (“[W]e hold that even if Pfizer showed that amlodipine besylate exhibits unexpectedly superior results, this secondary consideration does not overcome the strong showing of obviousness in this case. Although secondary considerations must be taken into account, they do not necessarily control the obviousness conclusion. Newell Cos., Inc. v. Kenney Mfg. Co., 864 F.2d 757, 768 (Fed.Cir.1988)”).

Pfizer, Inc. v. Apotex Inc., 480 F.3d 1348, 82 USPQd 1321 (Fed. Cir. 2007) 2143.01, 2145
HARMON 4: 92a, 315, 356, 363, 406, 428; 13: 299
DONNER 8: 92, 698

Newell Cos. v. Kenney Mfg. Co., 864 F.2d 757, 9 USPQ2d 1417 (Fed. Cir. 1988) 716.01(d), 716.04
HARMON 4: 33, 181

Tech Center 1700 Chemical & Materials Engineering
1712 Ex Parte Okada et al 11101573 - (D) HASTINGS 103 ANTONELLI, TERRY, STOUT & KRAUS, LLP HORNING, JOEL G

1765 Ex Parte CHUNG et al 12192476 - (D) PER CURIAM 102/103 BAYER MATERIAL SCIENCE LLC BUTTNER, DAVID J

Tech Center 2100 Computer Architecture and Software
2157 Ex Parte Imbimbo 11722849 - (D) CLEMENTS 103 ERICSSON INC. MINA, FATIMA P

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2859 Ex Parte Wang et al 11437350 - (D) ANDERSON 103 HAYNES AND BOONE, LLP PIGGUSH, AARON C

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3673 Ex Parte Schmidt 11294898 - (D) SCANLON 103 DAY PITNEY LLP CONLEY, FREDRICK C

3694 Ex Parte Antoo 11695499 - (D) MEDLOCK 103 VISA KILPATRICK TOWNSEND & STOCKTON LLP RANKINS, WILLIAM E

FEDERAL CIRCUIT

REVERSED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3733 SMITH & NEPHEW, INC., Appellant, v. TERESA STANEK REA, Acting Director, United States Patent and Trademark Office, Appellee, AND SYNTHES (U.S.A.) Appellee. 2012-1343 95/000,465 90/009,377 7,128,744 10/665,505 BRYSON 103 Knobbe, Martens, Olson, & Bear, LLP; United States Patent and Trademark Office; Woodcock Washburn LLP REIP, DAVID OWEN original SWIGER III, JAMES L

pfizer2, rinehart, zickendraht

custom search

REVERSED
1700 Chemical & Materials Engineering
1762 Ex Parte Xia et al 11382101 - (D) BEST 103 Loctite Corporation SASTRI, SATYA B

A combination of references only renders a claimed invention obvious if the skilled artisan would have had a reasonable expectation that the combination would work for its intended purpose. Pfizer, Inc. v. Apotex, Inc., 480 F.3d 1348, 1364 (Fed. Cir. 2007); In re Rinehart, 531 F.2d 1048, 1053-54 (CCPA 1976).

Pfizer, Inc. v. Apotex Inc., 480 F.3d 1348, 82 USPQd 1321 (Fed. Cir. 2007) . . . 2143.01, 2145

Rinehart, In re, 531 F.2d 1048, 189 USPQ 143 (CCPA 1976) . . . . . . . . . . . . . . .2107.02, 2142, 2143.02, 2144.04

2100 Computer Architecture and Software
2162 Ex Parte Wilson et al 10650904 - (D) POTHIER 103 IBM CORP C/O WINSTEAD P.C. GOFMAN, ALEX N

3700 Mechanical Engineering, Manufacturing, and Products & Design
3762 Ex Parte Singhal et al 10691917 - (D) WALSH 112(1) SHUMAKER & SIEFFERT, P. A. STOKLOSA, JOSEPH A

AFFIRMED-IN-PART
3700 Mechanical Engineering, Manufacturing, and Products & Design
3763 Ex Parte Berezowski et al 09823705 - (D) DANG 102/103 102 Tyco Healthcare Group LP d/b/a Covidien KOHARSKI, CHRISTOPHER

AFFIRMED
2100 Computer Architecture and Software
2197 Ex Parte Cromer et al 11394277 - (D) ZECHER 103 ROGITZ & ASSOCIATES PAN, HANG

2600 Communications
2624 Ex Parte Voronka et al 10958457 - (D) COURTENAY 112(2)/103/obviousness-type double patenting GIFFORD, KRASS, SPRINKLE,ANDERSON & CITKOWSKI, P.C FITZPATRICK, ATIBA O

The doctrine of double patenting seeks to prevent the unjustified extension of patent exclusivity beyond the term of a patent. The public policy behind this doctrine is that:

The public should . . . be able to act on the assumption that upon the expiration of the patent it will be free to use not only the invention claimed in the patent but also any modifications or variants thereof which would have been obvious to those of ordinary skill in the art at the time the invention was made, taking into account the skill [in] the art and prior art other than the invention claimed in the issued patent.

In re Zickendraht, 319 F.2d 225, 232 (CCPA 1963) (Rich, J., concurring).

Zickendraht, In re, 319 F.2d 225, 138 USPQ 22 (CCPA 1963) . .804, 804.03, 1504.06

2625 Ex Parte Aschenbrenner et al 10881522 - (D) CHEN 103 Yudell Isidore Ng Russell PLLC TRAN, DOUGLAS Q

2800 Semiconductors, Electrical and Optical Systems and Components
2833 Ex Parte Yoshida et al 11516787 - (D) GONSALVES 103 KANESAKA BERNER AND PARTNERS LLP FISHMAN, MARINA

2839 HENRY MILAN, Patent Owner and Appellant v. APPLE, INC., Third Party Requester and Respondent 95001083 6991483 10/987,242 MARTIN 112(1)/102/103 BUTZEL LONG REICHLE, KARIN M original ZARROLI, MICHAEL C

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3628 Ex Parte Albert et al 10645139 - (D) PETRAVICK 102/103 BAKER BOTTS L.L.P. ALLEN, AKIBA KANELLE

3700 Mechanical Engineering, Manufacturing, and Products & Design
3736 Ex Parte Miller 11147390 - (D) SCHEINER 103 WELSH FLAXMAN & GITLER LLC PANI, JOHN

3763 Ex Parte Wenchell 12503419 - (D) WALSH 103 Tyco Healthcare Group LP d/b/a Covidien KOHARSKI, CHRISTOPHER
 
REHEARING 

DENIED
1700 Chemical & Materials Engineering
1778 Ex Parte Halaka 11555975 - (D) FRANKLIN 112(1)/102/103 Talivaldis Cepuritis Olson & Cepuritis, Ltd. KURTZ, BENJAMIN M

pfizer2

REVERSED

1700 Chemical & Materials Engineering
1712 Ex Parte Johnson et al 11/881,211 GUEST 103(a) BAYER MATERIAL SCIENCE LLC EXAMINER ZHAO, XIAO SI

1721 Ex Parte Tan et al 10/970,077 GUEST 102(b)/103(a) LAW OFFICES OF MIKIO ISHIMARU EXAMINER JELSMA, JONATHAN G

1731 Ex Parte Nakashima et al 10/533,302 OWENS 103(a) KANESAKA BERNER AND PARTNERS LLP EXAMINER MCDONOUGH, JAMES E

1742 Ex Parte Steele 10/656057 OWENS 103(a) INVISTA NORTH AMERICA S.A.R.L. EXAMINER BUTLER, PATRICK NEAL

1762 Ex Parte Beckley et al 10/660,186 OWENS 103(a) ROHM AND HAAS COMPANY EXAMINER BERNSHTEYN, MICHAEL

1785 Ex Parte Kapkin 10/490,449 TIMM 103(a) ARENT FOX LLP EXAMINER AMAKWE, TAMRA L

2400 Networking, Mulitplexing, Cable, and Security
2456 Ex Parte Finn 10/282,438 SMITH 103(a) CAMPBELL STEPHENSON LLP EXAMINER BATES, KEVIN T

2477 Ex Parte Sohraby et al 10/115,519 WHITEHEAD, JR. 112(1)/103(a) Ryan, Mason & Lewis, LLP EXAMINER SEFCHECK, GREGORY B
AFFIRMED-IN-PART

3700 Mechanical Engineering, Manufacturing, and Products & Design
3724 Ex Parte Brunson et al 11/387,179 SPAHN 103(a) THE BLACK & DECKER CORPORATION EXAMINER ASHLEY, BOYER DOLINGER
REEXAMINATION

REHEARING DENIED

3900 Central Reexamination Unit (CRU)
3694 Ex parte Mainline Corporate Holdings, Limited Appellant and Patent Owner 90/010,191 7,328,188 TURNER 102(b)/103(a) PATENT OWNER: MESCHKOW & GRESHAM P.L.C. Lowell W. Gresham, Esq. THIRD-PARTY REQUESTER: TOWNSEND AND TOWNSEND AND CREW, LLP Irving E. Branch, Esq. EXAMINER JASTRZAB, JEFFREY R original EXAMINER TRAMMELL, JAMES P
AFFIRMED

1600 Biotechnology and Organic Chemistry
1629 Ex Parte Secrist et al 12/053,970 WALSH 103(a) CONNOLLY BOVE LODGE & HUTZ LLP (Southern Research Institute) EXAMINER BAEK, BONG-SOOK

1633 Ex Parte Droge et al 10/082,772 GREEN 103(a) Steven L. Highlander FULBRIGHT & JAWORSKI L.L.P. EXAMINER NGUYEN, QUANG

1700 Chemical & Materials Engineering
1727 Ex Parte Cherepy et al 10/913,573 TIMM 103(a) Lawrence Livermore National Security, LLC LAWRENCE LIVERMORE NATIONAL LABORATORY EXAMINER ENIN-OKUT, EDU E

1735 Ex Parte Yamashita et al 11/098,512 GAUDETTE 103(a) OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. EXAMINER IP, SIKYIN

"[B]y definition, any superior property must be unexpected to be considered as evidence of non-obviousness." Pfizer, Inc. v. Apotex, Inc., 480 F. 3d 1348, 1371 (Fed. Cir. 2007)

Pfizer, Inc. v. Apotex Inc., 480 F.3d 1348, 82 USPQd 1321 (Fed. Cir. 2007) . . . 2143.01, 2145

1761 Ex Parte Butler et al 11/475,282 TIMM 103(a) FINA TECHNOLOGY INC EXAMINER SZEKELY, PETER A

2100 Computer Architecture and Software
2177 Ex Parte Agrawala et al 10/788,503 JEFFERY 103(a) MICROSOFT CORPORATION EXAMINER FABER, DAVID

2600 Communications
2629 Ex Parte Johnson et al 10/535,296 KRIVAK 103(a) PHILIPS INTELLECTUAL PROPERTY & STANDARDS EXAMINER CHOW, YUK

3700 Mechanical Engineering, Manufacturing, and Products & Design
3748 Ex Parte Lifson et al 11/200,364 GREENHUT 102(b)/103(a) CARLSON, GASKEY & OLDS, P.C. EXAMINER DAVIS, MARY ALICE

3784 Ex Parte Stark et al 11/225,533 SAINDON 103(a) HARNESS, DICKEY, & PIERCE, P.L.C EXAMINER JIANG, CHEN WEN
REHEARING

DENIED

1600 Biotechnology and Organic Chemistry
1618 Ex Parte Fikstad et al 09/871,318 GRIMES 103(a) BINGHAM MCCUTCHEN LLP EXAMINER YOUNG, MICAH PAUL

NEW

REVERSED

3653 Ex Parte Coleman et al 11/222,580 HORNER 103(a) FISH & RICHARDSON P.C. (BO) EXAMINER BEAUCHAINE, MARK J

2456 Ex Parte Finn 10/282,438 SMITH 103(a) CAMPBELL STEPHENSON LLP EXAMINER
BATES, KEVIN T

2617 Ex Parte Ganesh 10/974,073 RUGGIERO 103(a) Honeywell International Inc. EXAMINER PATEL, NIMESH

3663 Ex Parte Han et al 11/342,760 CLARKE 103(a) YEE & ASSOCIATES P.C. EXAMINER KEITH, JACK W

3624 Ex Parte Nash et al 11/323,792 CRAWFORD 102(b)/103(a) SCHWEGMAN, LUNDBERG & WOESSNER/EBAY EXAMINER JARRETT, SCOTT L

3634 Ex Parte Sees 11/034,171 HORNER 103(a) FAEGRE & BENSON LLP EXAMINER KELLY, CATHERINE A

2163 Ex Parte Takatsuka et al 10/959,913 STEPHENS 103(a) HAMILTON, BROOK, SMITH & REYNOLDS, P.C. EXAMINER NGUYEN, KIM T

AFFIRMED

3632 Ex Parte Akouka et al 10/543,371 HOELTER 102(b)/103(a) RATNERPRESTIA EXAMINER DUCKWORTH, BRADLEY

2626 Ex Parte Coffman et al 10/701,784 BAUMEISTER 102(e)/103(a) TUTUNJIAN & BITETTO, P.C. EXAMINER JACKSON, JAKIEDA R

1723 Ex Parte Craig et al 10/103,411 STAICOVICI 103(a) EXAMINER WILKINS III, HARRY D FISH & RICHARDSON P.C. (BO)

3764 Ex Parte Daskal 09/489,655 BAHR 103(a) Charles R Macedo Amster Rothstein & Ebenstein EXAMINER ANDERSON, CATHARINE L

2186 Ex Parte Hilland et al 10/400,313 POTHIER 102(e) HEWLETT-PACKARD COMPANY EXAMINER PATEL, HETUL B

1643 Ex Parte Hung 10/622,743 GREEN 103(a) CYTYC CORPORATION EXAMINER SANG, HONG

2186 Ex Parte Rajakarunanayake 11/237,126 ZECHER 103(a) MCANDREWS HELD & MALLOY, LTD EXAMINER FISHBURN, JOHN P

REMANDED

2618 Ex Parte Anderson 10/917,968 BARTLETT after final amendment not considered FITCH EVEN TABIN & FLANNERY EXAMINER REGO, DOMINIC E

3767 Ex Parte Tucker 11/012,824 BARTLETT reply brief not considered LAW OFFICE OF LOUIS WOO EXAMINER GRAY, PHILLIP A